Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares — Chart, Price & News (NASDAQ:KNSA) | MetaTrader

Open full chart

Financials

Overview Finanzbericht Statistics Dividends

Quarterly Annual

Market Capitalization 3.3012 B
Employee 315
Founded 2015
CEO N/A
Website www.kiniksa.com
Headquarter N/A
FIGI N/A
Industry Technology

Total revenue

Net income

Basic earnings per share (Basic EPS)

Total debt

Free cash flow

Cash & equivalents

3.3 B Market capitalization

Price to earnings ratio

55

Price to sales ratio

4.81

Dividends per share

—

Dividend yield %

—

Nachrichten

Drug Stocks Lead Eight Hot New Names Onto IBD 50 List, Big Cap 20 And More

ASML, With Unique AI Tech, Leads 8 Hot Growth Stocks Joining IBD's Top Screens

Nurix Therapeutics Stock Sees RS Rating Jump To 82

Construction Star Leads 11 Hot Stocks To Various Best Growth Lists like IBD 50, Sector Leaders

Kiniksa Pharma: EPS verfehlt Schätzungen um 0,18 $ - Umsatz besser als erwartet

Kiniksa Pharma earnings missed by $0.18, revenue topped estimates

Kiniksa: Wedbush hebt Kursziel wegen Produkteinführungsaussichten auf 53 US-Dollar an

Wedbush raises Kiniksa stock price target to $53 on launch outlook

Kiniksa Pharmaceuticals International, plc 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:KNSA) 2026-02-24

Kiniksa Q4 2025 slides: ARCALYST drives 62% growth, profitability

Kiniksa vor Quartalszahlen: Wachstumstreiber ARCALYST im Fokus

Kiniksa earnings in focus as rare disease drug fuels growth